Dr. Stephanie Teotia, a distinguished board-certified plastic and reconstructive surgeon from Flower Mound, TX who serves patients in the Dallas area joins eHealth Radio and the Plastic Surgery Information Channel.
In today’s episode, Dr. Teotia,…
Omada, a virtual healthcare provider, announced Tuesday that it is expanding its GLP-1 companion solution to include musculoskeletal exercise programming and member-level reporting for employers, payers and pharmacy benefit managers.
San Francisco-based Omada serves employers,…
The direct-to-consumer (DTC) model of healthcare may be the future of healthcare delivery in regards to consumer access and potentially reducing bureaucracy. Even Eli Lilly is getting in on the action with LillyDirect for…
Continue Reading
Background: The Health eLiteracy for Prevention in General Practice trial is a primary health care–based behavior change intervention for weight loss in Australians who are overweight and those with obesity from lower socioeconomic areas….
Continue Reading
What You Should Know:
– Nudj Health, a leader in tech-enabled healthcare interventions, announces the launch of Nudj Cardiac Complete™.
– The innovative program combines Medicare-approved Virtual Intensive Cardiac Rehab (v-ICR) with evidence-based Collaborative Care to…
Continue Reading
According to the CDC, 42% of Americans are considered obese. There aren’t enough obesity medicine specialists to see them all. Brand medications are on the FDA shortage list and natural methods such as diet…
Continue Reading
What You Should Know:
– Vizient, Inc., a leading healthcare performance improvement company, has released its latest Pharmacy Market Outlook, projecting a 3.8% growth in drug price inflation.
– The increase is the highest since July…
Continue Reading
GLP-1 medications like Ozempic, Wegovy, and Mounjaro have ushered in a new era for the weight loss market in 2024 and surfaced several questions that have been festering for quite some time and can…
Continue Reading
News and social media are saturated with articles about the demand for and shortage of glucagon-like peptide-1 (GLP-1) drugs marketed for weight loss. The best-known of these drugs is semaglutide, sold under the brand…
Continue Reading
Background: With the increasing prevalence of obesity, weight loss has become a critical issue in China. Self-managed weight loss through a mobile health (mHealth) app may be a prospective method. However, its practicability in…
Continue Reading
